In-Vitro Lung Model Market Expansion 2024-2033: Growth Drivers and Dynamics

The in-vitro lung model global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

In-Vitro Lung Model Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The in vitro lung model market size has grown exponentially in recent years. It will grow from $0.37 billion in 2023 to $0.44 billion in 2024 at a compound annual growth rate (CAGR) of 21%. The growth in the historic period can be attributed to growing prevalence of respiratory diseases, increased focus on personalized medicine, growing interest in drug repurposing, emphasis on precision medicine approaches, growing awareness of environmental health risks.

The vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $0.96 billion in 2028 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Scope Of In-Vitro Lung Model Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

In-Vitro Lung Model Market Overview

Market Drivers –
The increase in clinical studies is expected to propel the growth of the in vitro lung model market going forward. Clinical trials refer to research studies that test how well new medical approaches work in people. The increase in clinical studies is driven by the growing need for advanced medical treatments, rising healthcare demands, and the pursuit of innovative solutions to complex health issues. In vitro lung models help in clinical trials by providing a controlled environment to study the effects of substances on lung tissue, aiding in drug testing, toxicity assessment, disease modeling, and understanding disease mechanisms. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, by the end of 2023, 477,230 clinical trials registered globally on ClinicalTrials.gov, an increase compared to 437,508 registered clinical trials in 2022. Therefore, the increase in clinical studies drives the in vitro lung model market.

Market Trends –
Major companies operating in the invitro lung model market are developing 3D respiratory tissue models to enhance their models’ physiological relevance and complexity. 3D respiratory tissue models are created by culturing selected respiratory cells in a specialized environment, allowing them to assemble into a three-dimensional structure miming the respiratory system’s function and morphology, providing a more physiologically relevant platform for research and drug testing. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. It replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and cilia that beat. The introduction of EpiNasal expands MatTek’s portfolio of 3D respiratory tissue models. This model offers a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Get an inside scoop of the in-vitro lung model market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Regional Insights –
North America was the largest region in the in-vitro lung model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies –
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc. , STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Table of Contents
1. Executive Summary
2. In-Vitro Lung Model Market Report Structure
3. In-Vitro Lung Model Market Trends And Strategies
4. In-Vitro Lung Model Market – Macro Economic Scenario
5. Global In-Vitro Lung Model Market Size and Growth
.
.
.
32. Global In-Vitro Lung Model Market Competitive Benchmarking
33. Global In-Vitro Lung Model Market Competitive Dashboard
34. Key Mergers And Acquisitions In The In-Vitro Lung Model Market
35. In-Vitro Lung Model Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model